Stock Track | Ardelyx Plummets 5.21% in Pre-market After Q1 Earnings Miss

Stock Track
05/01

Ardelyx (ARDX) shares plummeted 5.21% in pre-market trading on Friday following the release of the company's first-quarter financial results.

The biopharmaceutical company reported a net loss of $0.15 per diluted share for Q1, which missed analyst expectations of a $0.14 loss. Despite revenue for the quarter coming in at $94.5 million and exceeding consensus estimates, investors appeared to focus on the earnings miss.

The market reaction suggests traders were digesting the mixed quarterly performance, with the earnings shortfall outweighing the positive revenue surprise in pre-market trading.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10